Suchergebnisse - "Strub-Wourgaft, Nathalie"

PubPharm (5)

1

Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis : a multicentre, single-arm, open-label, phase 2-3 trial

enthalten in: The Lancet. Global health | 2022

von Kande Betu Kumesu, V. | Mutombo Kalonji, W. | Bardonneau, C. | +20

2

The Chagas disease study landscape : A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data platform

enthalten in: PLoS neglected tropical diseases | 2021

von Maguire, B. | Dahal, P. | Rashan, S. | +8

3

Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens : a proof-of-concept, randomised, placebo-controlled trial

enthalten in: The Lancet. Infectious diseases | 2018

von Torrico, F. | Gascon, J. | Ortiz, L. | +52

CommentIn: Lancet Infect Dis. 2018 Apr;18(4):363-365. - PMID 29352705

4

Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis : a pivotal multicentre, randomised, non-inferiority trial

enthalten in: Lancet (London, England) | 2018

von Mesu, V. | Kalonji, W. | Bardonneau, C. | +23

ErratumIn: Lancet. 2018 Jan 13;391(10116):124. - PMID 29129438

5

Determination of an optimal dosing regimen for fexinidazole, a novel oral drug for the treatment of human African trypanosomiasis : first-in-human studies

enthalten in: Clinical pharmacokinetics | 2014

von Tarral, A. | Blesson, S. | Mordt, O. | +8

1
[1]